
Ilit Turgeman, MD, is a thoracic medical oncologist and Advanced Clinical Fellow at the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute and Harvard Medical School. Her clinical and research work focuses on oncogene-driven lung cancer and precision oncology, with a particular interest in the origins and evolution of lung cancer and the interplay between inherited biology, environmental exposures, and tumor genomics. Her broader work explores climate change, sustainability, and health policy in cancer care. Prior to joining Dana-Farber, Dr. Turgeman held clinical and research leadership roles in Israel, including leading thoracic oncology and establishing a dedicated young-onset cancer service at Emek Medical Center, and later developing thoracic oncology research and clinical trials at Carmel and Lin Medical Centers in Haifa. She serves on the IASLC Global Policy and Partnerships Committee and holds international leadership roles with OUCH International. She earned her MD from Hebrew University Medical School, completed her Medical Oncology residency at Rambam Health Care Campus, and pursued fellowship training in early-phase clinical trials at the Sarah Cannon Research Institute in the United Kingdom.
Fellow
Medical School
2008 – 2015
Residency
2015 – 2021
Fellowship
2021 – 2022